How big is the AMD Drugs Market ?
AMD Drugs Market was valued at US$ 9,717.64 million in 2021 and is estimated to reach US$ 15,903.86 million by 2031.
Who are the Key Players of AMD Drugs Market ?
Major players are F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc, Novartis AG, Pfizer Inc, Kubota Pharmaceutical Holdings Inc, AbbVie Inc, Kodiak Sciences, Genentech Inc, Roche Group Member, and Regenxbio Inc.